Loading…

Contribution of tryptophan and its metabolites to transplant outcome: a mini-review

Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of inte...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2024-10, Vol.15, p.1395421
Main Authors: Donoso-Meneses, Darío, Padilla, Cristina, Moya-Guzmán, María José, Alegre, Maria-Luisa, Pino-Lagos, Karina
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3
container_end_page
container_issue
container_start_page 1395421
container_title Frontiers in immunology
container_volume 15
creator Donoso-Meneses, Darío
Padilla, Cristina
Moya-Guzmán, María José
Alegre, Maria-Luisa
Pino-Lagos, Karina
description Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of intestinal metabolism generated by both host cells and the microbiota have been identified as modulators of the immune response. Among these, tryptophan (Trp) and its derivatives are being investigated to understand their impact on alloimmunity and their potential usefulness as therapeutic targets to improve allograft survival. Here, we reviewed the latest findings on the contribution of Trp metabolic pathways to transplant outcomes.
doi_str_mv 10.3389/fimmu.2024.1395421
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_80ce93ef52db4c45b333019d7b68b1b0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_80ce93ef52db4c45b333019d7b68b1b0</doaj_id><sourcerecordid>3122633012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3</originalsourceid><addsrcrecordid>eNpVkUtP3DAUhS0EAgT8ARbIy24y-J24mwqNWkBC6qKwtvwKGCVxajtU_Pt6mAGBN7auz_2ufQ4A5xitKO3kZR_GcVkRRNgKU8kZwXvgGAvBGkoI2_90PgJnOT-jupiklPJDcEQlaxnD4hj8WceppGCWEuIEYw9Lep1LnJ_0BPXkYCgZjr5oE4dQfIYlVoWe8jzoqcC4FBtH_x1qOIYpNMm_BP_vFBz0esj-bLefgIdfP-_XN83d7-vb9dVdYykSpXFOdwZ3rWaatx1GVApLWqRtp7G3VmDSU05RW0WtbFkvOuk4xp702EjuDD0Bt1uui_pZzSmMOr2qqIN6K8T0qHQqwQ5edch6SX3PiTPMMm6qEQhL1xpR8QZV1o8ta17M6J311RU9fIF-vZnCk3qMLwpjXv_ASCV82xFS_Lv4XNQYsvVDNcrHJSuKCRGbqRsp2Uptijkn33_MwUht0lVv6apNumqXbm26-PzCj5b3LOl_Yy2iZg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3122633012</pqid></control><display><type>article</type><title>Contribution of tryptophan and its metabolites to transplant outcome: a mini-review</title><source>PubMed Central</source><creator>Donoso-Meneses, Darío ; Padilla, Cristina ; Moya-Guzmán, María José ; Alegre, Maria-Luisa ; Pino-Lagos, Karina</creator><creatorcontrib>Donoso-Meneses, Darío ; Padilla, Cristina ; Moya-Guzmán, María José ; Alegre, Maria-Luisa ; Pino-Lagos, Karina</creatorcontrib><description>Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of intestinal metabolism generated by both host cells and the microbiota have been identified as modulators of the immune response. Among these, tryptophan (Trp) and its derivatives are being investigated to understand their impact on alloimmunity and their potential usefulness as therapeutic targets to improve allograft survival. Here, we reviewed the latest findings on the contribution of Trp metabolic pathways to transplant outcomes.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2024.1395421</identifier><identifier>PMID: 39474416</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Animals ; Gastrointestinal Microbiome - immunology ; Graft Rejection - immunology ; Graft Rejection - metabolism ; Graft Survival - immunology ; Humans ; immune regulation ; Immunology ; microbiota ; Organ Transplantation ; tolerance ; transplantation ; Transplantation Tolerance ; Treatment Outcome ; trypthophan metabolism ; Tryptophan - metabolism</subject><ispartof>Frontiers in immunology, 2024-10, Vol.15, p.1395421</ispartof><rights>Copyright © 2024 Donoso-Meneses, Padilla, Moya-Guzmán, Alegre and Pino-Lagos.</rights><rights>Copyright © 2024 Donoso-Meneses, Padilla, Moya-Guzmán, Alegre and Pino-Lagos 2024 Donoso-Meneses, Padilla, Moya-Guzmán, Alegre and Pino-Lagos</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518742/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11518742/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39474416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Donoso-Meneses, Darío</creatorcontrib><creatorcontrib>Padilla, Cristina</creatorcontrib><creatorcontrib>Moya-Guzmán, María José</creatorcontrib><creatorcontrib>Alegre, Maria-Luisa</creatorcontrib><creatorcontrib>Pino-Lagos, Karina</creatorcontrib><title>Contribution of tryptophan and its metabolites to transplant outcome: a mini-review</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of intestinal metabolism generated by both host cells and the microbiota have been identified as modulators of the immune response. Among these, tryptophan (Trp) and its derivatives are being investigated to understand their impact on alloimmunity and their potential usefulness as therapeutic targets to improve allograft survival. Here, we reviewed the latest findings on the contribution of Trp metabolic pathways to transplant outcomes.</description><subject>Animals</subject><subject>Gastrointestinal Microbiome - immunology</subject><subject>Graft Rejection - immunology</subject><subject>Graft Rejection - metabolism</subject><subject>Graft Survival - immunology</subject><subject>Humans</subject><subject>immune regulation</subject><subject>Immunology</subject><subject>microbiota</subject><subject>Organ Transplantation</subject><subject>tolerance</subject><subject>transplantation</subject><subject>Transplantation Tolerance</subject><subject>Treatment Outcome</subject><subject>trypthophan metabolism</subject><subject>Tryptophan - metabolism</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtP3DAUhS0EAgT8ARbIy24y-J24mwqNWkBC6qKwtvwKGCVxajtU_Pt6mAGBN7auz_2ufQ4A5xitKO3kZR_GcVkRRNgKU8kZwXvgGAvBGkoI2_90PgJnOT-jupiklPJDcEQlaxnD4hj8WceppGCWEuIEYw9Lep1LnJ_0BPXkYCgZjr5oE4dQfIYlVoWe8jzoqcC4FBtH_x1qOIYpNMm_BP_vFBz0esj-bLefgIdfP-_XN83d7-vb9dVdYykSpXFOdwZ3rWaatx1GVApLWqRtp7G3VmDSU05RW0WtbFkvOuk4xp702EjuDD0Bt1uui_pZzSmMOr2qqIN6K8T0qHQqwQ5edch6SX3PiTPMMm6qEQhL1xpR8QZV1o8ta17M6J311RU9fIF-vZnCk3qMLwpjXv_ASCV82xFS_Lv4XNQYsvVDNcrHJSuKCRGbqRsp2Uptijkn33_MwUht0lVv6apNumqXbm26-PzCj5b3LOl_Yy2iZg</recordid><startdate>20241015</startdate><enddate>20241015</enddate><creator>Donoso-Meneses, Darío</creator><creator>Padilla, Cristina</creator><creator>Moya-Guzmán, María José</creator><creator>Alegre, Maria-Luisa</creator><creator>Pino-Lagos, Karina</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20241015</creationdate><title>Contribution of tryptophan and its metabolites to transplant outcome: a mini-review</title><author>Donoso-Meneses, Darío ; Padilla, Cristina ; Moya-Guzmán, María José ; Alegre, Maria-Luisa ; Pino-Lagos, Karina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Gastrointestinal Microbiome - immunology</topic><topic>Graft Rejection - immunology</topic><topic>Graft Rejection - metabolism</topic><topic>Graft Survival - immunology</topic><topic>Humans</topic><topic>immune regulation</topic><topic>Immunology</topic><topic>microbiota</topic><topic>Organ Transplantation</topic><topic>tolerance</topic><topic>transplantation</topic><topic>Transplantation Tolerance</topic><topic>Treatment Outcome</topic><topic>trypthophan metabolism</topic><topic>Tryptophan - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Donoso-Meneses, Darío</creatorcontrib><creatorcontrib>Padilla, Cristina</creatorcontrib><creatorcontrib>Moya-Guzmán, María José</creatorcontrib><creatorcontrib>Alegre, Maria-Luisa</creatorcontrib><creatorcontrib>Pino-Lagos, Karina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Donoso-Meneses, Darío</au><au>Padilla, Cristina</au><au>Moya-Guzmán, María José</au><au>Alegre, Maria-Luisa</au><au>Pino-Lagos, Karina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contribution of tryptophan and its metabolites to transplant outcome: a mini-review</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2024-10-15</date><risdate>2024</risdate><volume>15</volume><spage>1395421</spage><pages>1395421-</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Long-term tolerance in the absence of immunosuppressive drugs is a major goal in the transplantation field, not yet attained. Recent research on the role of commensal microbiota in the control of immunity has opened new avenues for the search of novel clinical interventions. Indeed, products of intestinal metabolism generated by both host cells and the microbiota have been identified as modulators of the immune response. Among these, tryptophan (Trp) and its derivatives are being investigated to understand their impact on alloimmunity and their potential usefulness as therapeutic targets to improve allograft survival. Here, we reviewed the latest findings on the contribution of Trp metabolic pathways to transplant outcomes.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>39474416</pmid><doi>10.3389/fimmu.2024.1395421</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2024-10, Vol.15, p.1395421
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_80ce93ef52db4c45b333019d7b68b1b0
source PubMed Central
subjects Animals
Gastrointestinal Microbiome - immunology
Graft Rejection - immunology
Graft Rejection - metabolism
Graft Survival - immunology
Humans
immune regulation
Immunology
microbiota
Organ Transplantation
tolerance
transplantation
Transplantation Tolerance
Treatment Outcome
trypthophan metabolism
Tryptophan - metabolism
title Contribution of tryptophan and its metabolites to transplant outcome: a mini-review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A03%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contribution%20of%20tryptophan%20and%20its%20metabolites%20to%20transplant%20outcome:%20a%20mini-review&rft.jtitle=Frontiers%20in%20immunology&rft.au=Donoso-Meneses,%20Dar%C3%ADo&rft.date=2024-10-15&rft.volume=15&rft.spage=1395421&rft.pages=1395421-&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2024.1395421&rft_dat=%3Cproquest_doaj_%3E3122633012%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c306t-dda8b187a4a57810396c270ac8a1ecc612f353078b17974f689d511e2f1b95db3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3122633012&rft_id=info:pmid/39474416&rfr_iscdi=true